Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) is a clinical syndrome defined by the presence of thrombocytopenia and microangiopathic hemolytic anemia without a clinically apparent etiology. Patients may also have multiple other symptoms and signs including neurologic and r
HLA-DR53 protects against thrombotic thrombocytopenic purpura/adult hemolytic uremic syndrome
β Scribed by Geetha Joseph; Kenneth J. Smith; Terence J. Hadley; Benjamin Djulbegovic; Gary M. Troup; John Oldfather; Robert L. Barker
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 720 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A retrospective analysis was made of 14 consecutive adults with hemolytic uremic syndromeithrombotic thrombocytopenic purpura (HUSiTTP) who were treated with plasma exchange (PE). In six patients the disease was primary, whilst in eight HUSiTTP was considered secondary to an associated condition. Th
## Abstract The Oklahoma TTPβHUS Registry provides a complete community perspective of thrombotic thrombocytopenic purpura (TTP). This is possible because plasma exchange is the essential treatment for TTP and the Oklahoma Blood Institute provides all plasma exchange procedures for a region encompa
## Abstract Thrombotic thrombocytopenic purpuraβhemolytic uremic syndrome (TTPβHUS) is more common in women, and commonly occurs during pregnancy and the immediate postpartum period. An important clinical issue is the distinction of TTPβHUS from the more common obstetric complications, preeclampsia